Figure S6 from IFNγ-Induced PD-L1<sup>+</sup>MHCII<sup>+</sup> Macrophages and Tim-3<sup>+</sup> Tumor-Reactive CD8<sup>+</sup> T Cells Predict a Response to Anti–PD-1 Therapy in Tumor-Bearing Mice
Gabrilo J., Vande Velde S., Henin C., Denanglaire S., Azouz A., Boon L., Van den Eynde BJ., Moser M., Goriely S., Leo O.
<p>Enhanced responsiveness to immunotherapy is associated with increased levels of terminally exhausted CD8 T cell signatures</p>